Depo-Provera Lawsuit

Last Updated: August 8, 2026 | Reviewed by: Legal Lawsuit Editorial Team | Primary Sources: U.S. District Court, N.D. Florida (MDL 3140); AboutLawsuits.com; FDA Quick Answer: A confidential Depo-Provera lawsuit settlement now covers nearly 6,300 federal meningioma brain-tumor claims after attorneys finalized a Master Settlement Agreement on July 27, 2026. Full eligibility and payout details [...]

Short Answer: The Depo-Provera lawsuit deadline by state generally falls between one and six years after diagnosis, depending on where you live and whether your state follows a "discovery rule." Miss that window and your claim may be permanently barred, so pin down your exact filing deadline with an attorney as early as you can. [...]

The Depo-Provera Rule 702 hearing on general causation moves to July 27, 2026. Here's what the ruling could mean if your case isn't covered by the settlement.

Short Answer: A Depo-Provera global settlement agreement in principle was announced on June 15, 2026, covering claims that the birth control injection caused meningioma brain tumors. Payout values, eligibility tiers, and timelines were still being worked out as of this update, so check your individual status with an attorney instead of counting on a set [...]

Texas Guide to Depo-Provera Meningioma Claims Depo-Provera Lawsuit Texas 2026: Finding a Depo Provera Lawyer in Texas, Deadlines and Filing Texas residents diagnosed with an intracranial meningioma after Depo-Provera or generic depot medroxyprogesterone acetate (DMPA) shots may want to talk with a Depo Provera lawyer in Texas about whether they can join the federal litigation. [...]

Short answer: Depo-Provera (medroxyprogesterone acetate) has been linked to an elevated risk of intracranial meningioma — a type of brain tumor. Over 12,000 lawsuits have been filed against Pfizer as of 2026, consolidated into a federal MDL in the Northern District of Illinois. Women who used Depo-Provera for one year or more and later developed [...]

🗓 Last Updated: July 16, 2026 ✅ Reviewed by: Legal Lawsuit Editorial Team 📚 Sources: FDA, Federal Court, BMJ, PubMed ⚖️ Topic: Depo-Provera MDL No. 3140 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is that Pfizer signed a Master [...]

Depo-Provera lawsuit update May 2026: MDL 3140 at 3,769+ cases, Daubert hearings active, statutes of limitations running. Who qualifies, settlement amounts. Call 1 (833) 333-0905.

Can you sue Depo-Provera for meningioma? Yes — 3,769+ cases in MDL 3140 against Pfizer. Eligibility, settlement amounts $50K–$500K+, how to file for free. Call 1 (833) 333-0905.

Depo-Provera meningioma lawsuit 2026: FDA-confirmed link between Depo-Provera and meningioma brain tumors. 3,769+ cases in MDL 3140. Who qualifies, settlement amounts, and how to file. Call 1 (833) 333-0905.

The Depo-Provera lawsuit 2026 is at a critical juncture with 3,790+ meningioma cases in MDL 3140 awaiting Daubert rulings. Learn who qualifies, settlement estimates, and how to file your claim before the deadline.

Breaking Depo-Provera lawsuit update: Pfizer files Daubert motion in the meningioma MDL ahead of June 24–26 causation hearings. 3,790 plaintiffs, settlement estimates $100K–$1.5M, who qualifies in 2026. Call 1 (833) 333-0905 for a free case review.

Get the latest Depo-Provera lawsuit update: 1,775+ MDL cases, meningioma risks, eligibility, settlements & how to join now.

Hire a Depo-Provera lawsuit attorney now. Fight Pfizer for meningioma risks from injections. Free consult, MDL updates & settlements up to $1.5M.